A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease

Authors

Michelle J. Nichols, Washington University School of Medicine in St. Louis
Johanna M. Hartlein, Washington University School of Medicine in St. LouisFollow
Meredith G.A Eicken, Washington University School of Medicine in St. Louis
Brad A. Racette, Washington University School of Medicine in St. Louis
Kevin J. Black, Washington University School of Medicine in St. Louis

Document Type

Open Access Publication

Journal

F1000Research

Volume

1

Issue

2

Publication Date

2013

Notes

Nichols MJ, Hartlein JM, Eicken MG et al. (2013) A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease [v1; ref status: approved 1, http://f1000r.es/1au] F1000Research 2013, 2:150 (doi: 10.12688/f1000research.2-150.v1) - See more at: http://f1000research.com/articles/2-150#sthash.ujfo2x6d.dpuf

Recommended Citation

Nichols, Michelle J.; Hartlein, Johanna M.; Eicken, Meredith G.A; Racette, Brad A.; and Black, Kevin J., "A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease" (2013). Psychiatry Faculty Publications. Paper 4.
Retrieved from https://digitalcommons.wustl.edu/psych_facpubs/4